Ewa Lech‐Marańda

7.4k total citations
134 papers, 1.7k citations indexed

About

Ewa Lech‐Marańda is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ewa Lech‐Marańda has authored 134 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Genetics, 47 papers in Pathology and Forensic Medicine and 41 papers in Hematology. Recurrent topics in Ewa Lech‐Marańda's work include Chronic Lymphocytic Leukemia Research (60 papers), Lymphoma Diagnosis and Treatment (41 papers) and Acute Lymphoblastic Leukemia research (23 papers). Ewa Lech‐Marańda is often cited by papers focused on Chronic Lymphocytic Leukemia Research (60 papers), Lymphoma Diagnosis and Treatment (41 papers) and Acute Lymphoblastic Leukemia research (23 papers). Ewa Lech‐Marańda collaborates with scholars based in Poland, United States and Germany. Ewa Lech‐Marańda's co-authors include Tadeusz Robak, Anna Korycka, Ewa Robak, Krzysztof Warzocha, Anna Wolska, Agata Wrzesień‐Kuś, Paweł Robak, Bertrand Coiffier, Gilles Salles and Jacques Bienvenu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ewa Lech‐Marańda

113 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Lech‐Marańda Poland 25 511 493 479 437 421 134 1.7k
Eric Van Den Neste Belgium 23 641 1.3× 592 1.2× 448 0.9× 384 0.9× 450 1.1× 79 1.6k
Roberto Cairoli Italy 22 725 1.4× 703 1.4× 446 0.9× 516 1.2× 302 0.7× 130 2.1k
Vincent Ribrag France 19 382 0.7× 505 1.0× 854 1.8× 390 0.9× 907 2.2× 80 1.9k
S.A. Johnson United Kingdom 21 774 1.5× 411 0.8× 587 1.2× 716 1.6× 456 1.1× 35 2.0k
Todd Covey United States 14 556 1.1× 318 0.6× 487 1.0× 663 1.5× 301 0.7× 33 1.4k
Michael Doubek Czechia 23 984 1.9× 612 1.2× 676 1.4× 510 1.2× 519 1.2× 169 2.3k
E. Thiel Germany 28 352 0.7× 698 1.4× 442 0.9× 425 1.0× 646 1.5× 121 2.5k
Tanya Trippett United States 24 235 0.5× 580 1.2× 380 0.8× 197 0.5× 655 1.6× 79 1.9k
Hyeoung‐Joon Kim South Korea 29 524 1.0× 1.0k 2.1× 436 0.9× 957 2.2× 909 2.2× 213 3.0k
Mariagrazia Michieli Italy 24 376 0.7× 527 1.1× 553 1.2× 162 0.4× 1.2k 2.8× 107 1.9k

Countries citing papers authored by Ewa Lech‐Marańda

Since Specialization
Citations

This map shows the geographic impact of Ewa Lech‐Marańda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Lech‐Marańda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Lech‐Marańda more than expected).

Fields of papers citing papers by Ewa Lech‐Marańda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Lech‐Marańda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Lech‐Marańda. The network helps show where Ewa Lech‐Marańda may publish in the future.

Co-authorship network of co-authors of Ewa Lech‐Marańda

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Lech‐Marańda. A scholar is included among the top collaborators of Ewa Lech‐Marańda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Lech‐Marańda. Ewa Lech‐Marańda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Drozd‐Sokołowska, Joanna, Anna Waszczuk‐Gajda, Magdalena Witkowska, et al.. (2022). Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group. Journal of Clinical Medicine. 11(15). 4447–4447. 1 indexed citations
4.
Mesa, Ruben A., Claire Harrison, Stephen T. Oh, et al.. (2022). Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis. Leukemia. 36(9). 2261–2268. 40 indexed citations
5.
Cochrane, Tara, Alicia Enrico, David Gómez‐Almaguer, et al.. (2021). Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & lymphoma. 63(2). 304–314. 6 indexed citations
6.
Jurczak, Wojciech, Suman Kambhampati, Ewa Lech‐Marańda, et al.. (2021). Favorable Outcomes for Patients Treated with U2 with Co-Morbidities or Concomitant Medications: A Retrospective Analysis of Unity-CLL Phase 3 Trial. Blood. 138(Supplement 1). 3748–3748. 2 indexed citations
7.
Wątek, Marzena, Ewelina Piktel, Tomasz Wollny, et al.. (2019). Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development. International Journal of Molecular Sciences. 20(4). 843–843. 25 indexed citations
8.
Jahnz‐Różyk, Karina, Marek Brzosko, Ewa Lech‐Marańda, et al.. (2019). The Polish Expert Group Position Statement on the Safety of Biological Treatments with Monoclonal Antibodies and Fusion Proteins: An Update. 9–9. 1 indexed citations
9.
Wątek, Marzena, Ewelina Piktel, Joanna Barankiewicz, et al.. (2019). Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma. International Journal of Molecular Sciences. 20(23). 6048–6048. 6 indexed citations
10.
Pawłowska, Małgorzata, Robert Flisiak, Lidia Gil, et al.. (2019). Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation. Clinical and Experimental Hepatology. 5(3). 195–202. 20 indexed citations
11.
Pyrzyńska, Beata, Abdessamad Zerrouqi, Giulia Morlino, et al.. (2018). FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. OncoImmunology. 7(5). e1423183–e1423183. 18 indexed citations
12.
Robak, Tadeusz, Andrzej Hellmann, Janusz Kłoczko, et al.. (2016). Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia. British Journal of Haematology. 176(4). 618–628. 30 indexed citations
13.
Kruk, Barbara, et al.. (2015). High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma. Leukemia & lymphoma. 56(12). 3348–3356. 4 indexed citations
14.
Tomkiewicz, Anna, Edyta Pawlak, Olga Grzybowska‐Izydorczyk, et al.. (2013). Intronic SNP - rs9288953 Of Suppressor Molecule Btla Confers Susceptibility To B-Cell Chronic Lymphocytic Leukemia. Blood. 122(21). 5286–5286. 1 indexed citations
15.
Lech‐Marańda, Ewa, Olga Grzybowska‐Izydorczyk, Krystyna Wyka, et al.. (2012). Serum Tumor Necrosis Factor-α and Interleukin-10 Levels as Markers to Predict Outcome of Patients with Chronic Lymphocytic Leukemia in Different Risk Groups Defined by the IGHV Mutation Status. Archivum Immunologiae et Therapiae Experimentalis. 60(6). 477–486. 15 indexed citations
16.
Warzocha, Krzysztof & Ewa Lech‐Marańda. (2011). Diagnosis and treatment of non-Hodgkin lymphomas. Postępy Nauk Medycznych. 1 indexed citations
17.
Sokołowska‐Wojdyło, Małgorzata, et al.. (2010). Leczenie pierwotnych chłoniaków skóry. Rekomendacje Sekcji Chłoniaków Skóry Polskiej Grupy Badawczej Chłoniaków (PLRG). SHILAP Revista de lepidopterología. 2 indexed citations
18.
Góra‐Tybor, Joanna, Krzysztof Jamroziak, Anna Szmigielska‐Kapłon, et al.. (2009). Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 50(1). 62–67. 14 indexed citations
19.
Lech‐Marańda, Ewa, Anna Korycka, & Tadeusz Robak. (2009). Clofarabine as a Novel Nucleoside Analogue Approved to Treat Patients with Haematological Malignancies: Mechanism of Action and Clinical Activity. Mini-Reviews in Medicinal Chemistry. 9(7). 805–812. 19 indexed citations
20.
Korycka, Anna, Ewa Lech‐Marańda, & Tadeusz Robak. (2008). Novel Purine Nucleoside Analogues for Hematological Malignancies. Recent Patents on Anti-Cancer Drug Discovery. 3(2). 123–136. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Van Den Neste Breakdown of academic impact, for papers by Roberto Cairoli Breakdown of academic impact, for papers by Vincent Ribrag Breakdown of academic impact, for papers by S.A. Johnson Breakdown of academic impact, for papers by Todd Covey Breakdown of academic impact, for papers by Michael Doubek Breakdown of academic impact, for papers by E. Thiel Breakdown of academic impact, for papers by Tanya Trippett Breakdown of academic impact, for papers by Hyeoung‐Joon Kim Breakdown of academic impact, for papers by Mariagrazia Michieli
Rankless by CCL
2026